Device
ANTERION
ANTERION is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completed
The Heidelberg Engineering ANTERION Corneal Epithelium Thickness Precision and Agreement Study
NCT05051813
completed
The Heidelberg Engineering ANTERION Anterior Segment Metrics Precision and Agreement Study
NCT04083742
completed
The Heidelberg Engineering ANTERION Anterior Segment Cornea and IOL Precision and Agreement Study
NCT04130490
completed
The Heidelberg Engineering ANTERION Imaging Agreement Study
NCT04068818
Clinical Trials (4)
Showing 4 of 4 trials
NCT05051813
The Heidelberg Engineering ANTERION Corneal Epithelium Thickness Precision and Agreement Study
NCT04083742
The Heidelberg Engineering ANTERION Anterior Segment Metrics Precision and Agreement Study
NCT04130490
The Heidelberg Engineering ANTERION Anterior Segment Cornea and IOL Precision and Agreement Study
NCT04068818
The Heidelberg Engineering ANTERION Imaging Agreement Study
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4